Study Of Pharmacokinetic (PK) Profile of Bazedoxifene (BZA) in 2 BZA/Conjugated Estrogen Forms
Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to understand how bazedoxifene is absorbed in the body when it is
given in combination with 2 different formulations of conjugated estrogens. It is an open
label study with no placebo control or comparator drugs. Subjects will take one dose of the
investigation formulation daily for 14 days.